Harm Reduction and Naloxone Access Course

These webinars are sponsored by Emergent BioSolutions, the manufacturer of Naloxone nasal spray.

The opioid crisis in Indigenous communities across Canada is a complex and urgent issue that requires comprehensive and culturally relevant solutions. Addressing this crisis involves acknowledging historical injustices, improving access to healthcare, and supporting community-driven initiatives.

Communities accessing naloxone has been identified as a barrier that needs to be addressed. Health directors, health and social professionals, and leaders working in or supporting various services and programs must be educated on obtaining naloxone to make it available to community members.

Intended Audience

The program is designed for:

• Health Directors
• Health and social professional and leaders working in or supporting various community services and programs
• Provinces included are Manitoba, Saskatchewan, Alberta, New Brunswick, Nova Scotia, Prince Edward Island and Newfoundland

Learning Objectives

Upon program completion, learners will have gained knowledge related to:

1. Understand the opioid crises in Canada and Indigenous communities.
2. Review of harm reduction and safe use of naloxone.
3. How to communicate and support staff and community members in accessing naloxone.

This is a virtual program provided in one session (1 hour).

This program can be delivered in-person upon request.

Our refund policy is designed to ensure clarity and fairness for all participants. Please review the Refund Policy for details on eligibility, timelines, and processes. For questions or assistance, contact us directly.